Glass Industry News

SGD Pharma advances sustainable manufacturing and supply chain innovation at DCAT Week 2025 in New York

, SGD Pharma

SGD Pharma, a global market leader in pharmaceutical glass primary packaging solutions, leads the charge towards greater sustainability and innovation by highlighting its multi-million investments into the next-generation of glass manufacturing and commitment to strengthening pharma supply chains in the US and beyond. DCAT Week takes place between 17th-20th March 2025 and is one of the most influential gatherings for pharmaceutical and biotech companies from across the world, providing a powerful platform for high-level discussions, networking and collaboration with key industry leaders.

SGD Pharma has committed multi-million-euro investment in recent years to modernize its global manufacturing sites, strengthen its high-precision vial production to meet growing pharma demand and upgrade its furnaces to reduce carbon emissions and energy use. SGD Pharma has been recognized by EcoVadis with a platinum medal for 2024 – placing it in the top 1% of the glass industry (and all companies evaluated) and the company’s decarbonization targets have been validated by the Science Based Targets initiative (SBTi), marking an important milestone in the company’s decarbonization journey.

Fabio Invernizzi, General Manager BU West and Carole Grassi Mircich, Chief Commercial Marketing & Innovation Officer will be attending to support SGD Pharma’s US team in strategic discussions. Carole adds “I am excited to attend DCAT Week and reconnect with our valued customers and partners. We are eager to dive deep into understanding their evolving needs, showcase our cutting-edge innovations, and explore new opportunities for collaboration that will drive the future of our industry.”

SGD Pharma continues to drive innovation in pharmaceutical packaging with significant investments and advancements. As proof of our commitment to continuing investment into the quality of our products, SGD Pharma opened a new siliconization operation at its Saint-Quentin Lamotte (SQLM) plant to provide customers with Sealian glass treatment which provides a protective barrier for sensitive, aggressive, and viscous drug products across all administration routes. Additionally, its IDENCY Type I glass vials offer increased chemical durability for parenteral drugs while maintaining compatibility with standard fill & finish processes for improved efficiency. To accelerate market delivery, SGD Pharma has expanded its Sterinity EZ-fill®* ready-to-use (RTU) vial offerings, reducing operational complexities and costs for pharma companies. Further optimizing production, Velocity® Vials—developed with Corning—feature a friction-reducing outer coating, improving manufacturing efficiency by up to 50% and minimizing disruptions. Through these advancements, SGD Pharma reinforces its commitment to innovation, ensuring high-quality, efficient, and reliable packaging solutions for the evolving pharmaceutical industry.

With increasing regulatory demands and growing expectations for eco-conscious production, SGD Pharma is committed to delivering pharmaceutical glass packaging solutions that enhance drug safety and efficiency while setting industry benchmarks in sustainability. At DCAT week, the team will engage with existing partners, customers and industry stakeholders as well as forge new partnerships to explore how the company can continue to create meaningful, impactful solutions to address the most pressing challenges faced by the pharmaceutical industry. Contact SGD Pharma to set up a meeting.

 

, © SGD Pharma

此网站新闻材料的版权属于公司或第三方的新闻提供者,其所有权利保留。所有新闻材料对其访问者只能限于其本人使用,并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供,当应用此新闻材料时,每个使用者都同意遵守,并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.



Info Grid

Glass studies

Updated worldwide glass study 2025

plants.glassglobal.com

Updated hollow glass study 2025

Request more information

Updated float glass study 2025

Request more information

Further glass market studies

Request more information

公司简介



Updated worldwide glass market study 2025 available now for flat, container glass and tableware

We have updated our international studies on flat glass, container glass and tableware for 2025.

This unique software provides a global overview about glass producers and technical details. Easy to use and clear tables summarize information and data about glass makers such as: Glass types: flat glass, container glass, tableware, production capacities in regions and countries, number of furnaces, furnace types, year of construction, glass types and sub-types, products, project information, special news and downloads.

Further databases supplying demoscopic data and import and export data complete the market survey. Based on these data, prepare individual country profiles with information about local production capacities, local market sizes and expected demand in the future.

Request your offer via plants.glassglobal.com.

Updated container glass study 2025

X

Updated float glass study 2025

X

Further glass studies and reports 2025

X